Carlsmed, Inc. CARL
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 13.80% | 17.52% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.80% | 17.52% | |||
| Cost of Revenue | 11.16% | 19.15% | |||
| Gross Profit | 14.60% | 17.04% | |||
| SG&A Expenses | 17.65% | 18.25% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.27% | 18.05% | |||
| Operating Income | -15.09% | -18.97% | |||
| Income Before Tax | -16.51% | -20.86% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -16.51% | -20.86% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -16.51% | -20.86% | |||
| EBIT | -15.09% | -18.97% | |||
| EBITDA | -15.30% | -18.84% | |||
| EPS Basic | -16.04% | -19.29% | |||
| Normalized Basic EPS | -16.02% | -19.31% | |||
| EPS Diluted | -16.04% | -19.29% | |||
| Normalized Diluted EPS | -16.02% | -19.31% | |||
| Average Basic Shares Outstanding | 0.41% | 1.32% | |||
| Average Diluted Shares Outstanding | 0.41% | 1.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||